AAAAAA
Results:
1-12
|
Results: 12
Authors:
PIZZOCARO G
SALVIONI R
NICOLAI N
PIVA L
MILANI A
MERSON M
COLAVITA M
Citation: G. Pizzocaro et al., ROLE OF POSTOPERATIVE CHEMOTHERAPY (CT) IN RADICALLY RESECTED RESIDUAL CANCER (CA) IN ADVANCED NON SEMINOMATOUS GERM-CELL TUMORS (NSGCT) INTHE MALE, The Journal of urology, 159(5), 1998, pp. 173-173
Authors:
PIZZOCARO G
PIVA L
DIPALO A
GROSSO G
COLAVITA M
Citation: G. Pizzocaro et al., ADJUVANT INTERFERON (IFN) TO RADICAL NEPHRECTOMY IN ROBSONS STAGE-II AND STAGE-III RENAL-CELL CANCER (RCC) - A MULTICENTER RANDOMIZED STUDY, The Journal of urology, 159(5), 1998, pp. 570-570
Authors:
FERRARI A
CASANOVA M
MASSIMINO M
LUKSCH R
PIVA L
FOSSATIBELLANI F
Citation: A. Ferrari et al., THE MANAGEMENT OF PARATESTICULAR RHABDOMYOSARCOMA - A SINGLE INSTITUTIONAL EXPERIENCE WITH 44 CONSECUTIVE CHILDREN, The Journal of urology, 159(3), 1998, pp. 1031-1034
Authors:
MALTONI M
PIROVANO M
NANNI O
MARINARI M
INDELLI M
GRAMAZIO A
TERZOLI E
LUZZANI M
DEMARINIS F
CARACENI A
LABIANCA R
SCARPI E
INNOCENTI MP
VINCI M
CENTRONE G
MARZOLA M
GIACCON G
ARNOLDI E
GALLUCCI M
FRONTINI L
PIVA L
ZANINETTA G
PETRELLA V
BARNI S
BERETTA G
CALIA C
MORO G
CARDAMONE I
GROFF L
AMADORI D
Citation: M. Maltoni et al., BIOLOGICAL INDEXES PREDICTIVE OF SURVIVAL IN 519 ITALIAN TERMINALLY ILL CANCER-PATIENTS, Journal of pain and symptom management, 13(1), 1997, pp. 1-9
Authors:
PIZZOCARO G
PIVA L
BANDIERAMONTE G
TANA S
Citation: G. Pizzocaro et al., UP-TO-DATE MANAGEMENT OF CARCINOMA OF THE PENIS, European urology, 32(1), 1997, pp. 5-15
Authors:
PIZZOCARO G
PIVA L
NICOLAI N
Citation: G. Pizzocaro et al., ADJUVANT AND NEOADJUVANT CHEMOTHERAPY FOR NODAL METASTASES FROM SQUAMOUS-CELL CARCINOMA (SCC) OF THE PENIS, European journal of cancer, 31A, 1995, pp. 472-472
Authors:
PIZZOCARO G
NICOLAI N
PIVA L
SALVIONI R
Citation: G. Pizzocaro et al., POSTORCHIECTOMY MARKERS ELEVATION ONLY IN NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT) OF THE TESTIS, European journal of cancer, 31A, 1995, pp. 918-918
Authors:
MALTONI M
PIROVANO M
SCARPI E
MARINARI M
INDELLI M
ARNOLDI E
GALLUCCI M
FRONTINI L
PIVA L
AMADORI D
Citation: M. Maltoni et al., PREDICTION OF SURVIVAL OF PATIENTS TERMINALLY ILL WITH CANCER - RESULTS OF AN ITALIAN PROSPECTIVE MULTICENTRIC STUDY, Cancer, 75(10), 1995, pp. 2613-2622
Authors:
FACENDOLA G
LOCATELLI MC
PIZZOCARO G
PIVA L
PEGORARO C
PALLAVICINI EB
SIGNAROLDI A
MEREGALLI M
LOMBARDI F
BERETTA GD
SCANZI F
LABIANCA R
LUPORINI G
Citation: G. Facendola et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED RENAL-CELL CARCINOMA - A CONFIRMATORY STUDY, British Journal of Cancer, 72(6), 1995, pp. 1531-1535
Authors:
TOSCANI F
PIVA L
CORLI O
GALLUCCI M
SPERANZA R
TAMBURINI M
DECONNO F
VENTAFRIDDA V
Citation: F. Toscani et al., KETOROLAC VERSUS DICLOFENAC SODIUM IN CANCER PAIN, Arzneimittel-Forschung, 44-1(4), 1994, pp. 550-554
Authors:
NICOLAI N
MANGIAROTTI B
SALVIONI R
PIVA L
FAUSTINI M
PIZZOCARO G
Citation: N. Nicolai et al., DEXAMETHASONE PLUS ONDANSETRON VERSUS DEXAMETHASONE PLUS ALIZAPRIDE IN THE PREVENTION OF EMESIS INDUCED BY CISPLATIN-CONTAINING CHEMOTHERAPIES FOR UROLOGICAL CANCERS, European urology, 23(4), 1993, pp. 450-456
Authors:
PIZZOCARO G
SALVIONI R
PIVA L
FAUSTINI M
NICOLAI N
GIANNI L
Citation: G. Pizzocaro et al., MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS, Annals of oncology, 3(3), 1992, pp. 211-216
Risultati:
1-12
|